Accelerated Approval: Makena Real-World Evidence Insufficient To Verify Clinical Benefit, CDER Says

 
• By Sue Sutter
  
Door closed
CDER has closed the door on any bid by Covis to rely solely on real-world evidence to confirm Makena's clinical benefit. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials